ATA247489A - Festes pharmazeutisches piroxicam-präparat und verfahren zu seiner herstellung - Google Patents

Festes pharmazeutisches piroxicam-präparat und verfahren zu seiner herstellung

Info

Publication number
ATA247489A
ATA247489A AT0247489A AT247489A ATA247489A AT A247489 A ATA247489 A AT A247489A AT 0247489 A AT0247489 A AT 0247489A AT 247489 A AT247489 A AT 247489A AT A247489 A ATA247489 A AT A247489A
Authority
AT
Austria
Prior art keywords
piroxicam
preparation
production
solid pharmaceutical
pharmaceutical
Prior art date
Application number
AT0247489A
Other languages
English (en)
Other versions
AT399277B (de
Inventor
Pal Dr Chem Ing Fekete
Denes Bezzegh
Istvan Dr Simonyi
Biborka Dr Maroshelyi
Katalin Zukovics
Janos Tombor
Original Assignee
Egyt Gyogyszervegyeszeti Gyar
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Egyt Gyogyszervegyeszeti Gyar filed Critical Egyt Gyogyszervegyeszeti Gyar
Publication of ATA247489A publication Critical patent/ATA247489A/de
Application granted granted Critical
Publication of AT399277B publication Critical patent/AT399277B/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/143—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/145—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/146—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Inorganic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
AT0247489A 1988-10-28 1989-10-27 Festes pharmazeutisches piroxicam-präparat und verfahren zu seiner herstellung AT399277B (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
HU885621A HU200926B (en) 1988-10-28 1988-10-28 Pharmaceutical composition comprising piroxicam and lactose for use in making tablets or capsules

Publications (2)

Publication Number Publication Date
ATA247489A true ATA247489A (de) 1994-09-15
AT399277B AT399277B (de) 1995-04-25

Family

ID=10970484

Family Applications (1)

Application Number Title Priority Date Filing Date
AT0247489A AT399277B (de) 1988-10-28 1989-10-27 Festes pharmazeutisches piroxicam-präparat und verfahren zu seiner herstellung

Country Status (9)

Country Link
JP (1) JPH02172918A (de)
AT (1) AT399277B (de)
CA (1) CA2001673C (de)
DE (1) DE3936112C2 (de)
FR (1) FR2638357B1 (de)
GB (1) GB2224207B (de)
HU (1) HU200926B (de)
IL (1) IL92138A (de)
IT (1) IT1239542B (de)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2642486B2 (ja) * 1989-08-04 1997-08-20 田辺製薬株式会社 難溶性薬物の超微粒子化法
JP2964195B2 (ja) * 1992-04-28 1999-10-18 エスエス製薬株式会社 ピロキシカム錠及びその製造法
DE19603402A1 (de) * 1995-02-24 1996-08-29 Basf Ag Weichgelatinekapseln
DE69733476T2 (de) * 1996-06-14 2006-03-23 Kyowa Hakko Kogyo Co., Ltd. Im munde schnellzerfallende tablette
US8071128B2 (en) 1996-06-14 2011-12-06 Kyowa Hakko Kirin Co., Ltd. Intrabuccally rapidly disintegrating tablet and a production method of the tablets
AU763143B2 (en) * 1998-04-08 2003-07-17 Kyowa Hakko Kirin Co., Ltd. Tablet manufacturing method and tablet
JP2000095674A (ja) * 1998-09-22 2000-04-04 Sato Pharmaceutical Co Ltd 口腔内崩壊時間短縮化錠剤の製造方法及び装置
US9358214B2 (en) 2001-10-04 2016-06-07 Adare Pharmaceuticals, Inc. Timed, sustained release systems for propranolol
CN100339078C (zh) * 2002-12-16 2007-09-26 橘生药品工业株式会社 固体口服剂型药物
US8367111B2 (en) 2002-12-31 2013-02-05 Aptalis Pharmatech, Inc. Extended release dosage forms of propranolol hydrochloride
US8747895B2 (en) 2004-09-13 2014-06-10 Aptalis Pharmatech, Inc. Orally disintegrating tablets of atomoxetine
US9884014B2 (en) 2004-10-12 2018-02-06 Adare Pharmaceuticals, Inc. Taste-masked pharmaceutical compositions
US20060105039A1 (en) 2004-10-21 2006-05-18 Jin-Wang Lai Taste-masked pharmaceutical compositions with gastrosoluble pore-formers
US9161918B2 (en) 2005-05-02 2015-10-20 Adare Pharmaceuticals, Inc. Timed, pulsatile release systems
ES2371414T3 (es) 2005-07-25 2012-01-02 Otsuka Pharmaceutical Co., Ltd. Preparación oral para medir la capacidad metabólica de la pirimidina.
CN108159019A (zh) 2009-12-02 2018-06-15 阿黛尔药物有限公司 非索非那定微胶囊及含有非索非那定微胶囊的组合物
CA2882528A1 (en) 2012-08-20 2014-02-27 Otsuka Pharmaceutical Co., Ltd. Method for measuring carbohydrate metabolism ability, and composition for use in said method
JP6305392B2 (ja) 2013-03-15 2018-04-04 大塚製薬株式会社 脂肪酸燃焼によるインスリン抵抗性の測定方法、並びにそれに使用する組成物

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3591584A (en) * 1968-08-27 1971-07-06 Pfizer Benzothiazine dioxides
GB1308533A (en) * 1969-06-02 1973-02-21 Pfizer Benzothiazine dioxides as anti-thombotic agents
JPS55129221A (en) * 1979-03-29 1980-10-06 Kaken Pharmaceut Co Ltd Preparation of oral preparation containing hardly soluble medicine
US4350689A (en) * 1980-02-15 1982-09-21 American Cyanamid Company Combinations of agents which give enhanced anti-inflammatory activity
US4434164A (en) * 1981-06-01 1984-02-28 Pfizer Inc. Crystalline benzothiazine dioxide salts
RO88420A (ro) * 1983-04-25 1986-01-30 Pfizer Inc,Us Procedeu pentru prepararea unor saruri bazice de piroxican depuse pe suporturi farmaceutice
DE3419128A1 (de) * 1984-05-23 1985-11-28 Bayer Ag, 5090 Leverkusen Dihydropyridinpraeparate und verfahren zu ihrer herstellung
CH663899A5 (fr) * 1985-03-20 1988-01-29 Nestle Sa Procede pour la preparation d'une composition a base d'un principe actif de faible hydrosolubilite finement divise.
ES8603754A1 (es) * 1985-07-02 1986-01-01 Ferrer Int Procedimiento de obtencion de particulas de 4-hidroxi-2-me- til-n-2-piridil-2h-1,2-benzotiazina-3-carboxamida-1,1-dioxi-do(piroxicam) recubiertas

Also Published As

Publication number Publication date
JPH02172918A (ja) 1990-07-04
HU200926B (en) 1990-09-28
CA2001673A1 (en) 1990-04-28
GB8924286D0 (en) 1989-12-13
HUT51143A (en) 1990-04-28
DE3936112C2 (de) 1999-02-18
CA2001673C (en) 1996-08-27
FR2638357A1 (fr) 1990-05-04
DE3936112A1 (de) 1990-05-31
IT8922164A1 (it) 1991-04-27
IL92138A0 (en) 1990-07-12
GB2224207A (en) 1990-05-02
IT1239542B (it) 1993-11-05
FR2638357B1 (fr) 1993-10-22
IL92138A (en) 1994-08-26
GB2224207B (en) 1992-06-10
AT399277B (de) 1995-04-25
IT8922164A0 (it) 1989-10-27

Similar Documents

Publication Publication Date Title
ATA125988A (de) Pharmazeutische cefuroximaxetil-zusammensetzung und verfahren zu ihrer herstellung
DE68905448D1 (de) Siliziumpulver und verfahren zu seiner herstellung.
DE68907876D1 (de) Substanz dc 113 und verfahren zu ihrer herstellung.
DE68902534D1 (de) Kapazitiver beschleunigungsmesser und verfahren zu seiner herstellung.
ATA176789A (de) Intravenös anwendbare pharmazeutische präparate und verfahren zu ihrer herstellung
ATA112089A (de) Harzadsorbat ranitidinpräparate und verfahren zu ihrer herstellung
ATA102392A (de) Topisches terbinafinpräparat und verfahren zu seiner herstellung
DE58904551D1 (de) Drucksensor und verfahren zu seiner herstellung.
DE68926448D1 (de) Bildsensor und verfahren zu dessen herstellung
DE68927087D1 (de) Sauerstoffempfindlicher Sensor und Verfahren zu dessen Herstellung
DE68909712D1 (de) Biomedizinisches Material und Verfahren zu seiner Herstellung.
DE3867724D1 (de) Modifiziertes feinpulveriges polytetrafluoraethylen und verfahren zu seiner herstellung.
ATA247489A (de) Festes pharmazeutisches piroxicam-präparat und verfahren zu seiner herstellung
DE3775294D1 (de) Implantatwerkstoff und verfahren zu seiner herstellung.
DE3782994D1 (de) Erythromycin-a-derivate und verfahren zu ihrer herstellung.
DE69002355D1 (de) Nahrungsmittel und verfahren zu seiner herstellung.
DE69625176D1 (de) Camptothecin-derivate und verfahren zu ihrer herstellung
DE3862937D1 (de) 3-oxo-propannitril heteroarylderivate und verfahren zu deren herstellung.
DE3687775D1 (de) Polymerpartikel und verfahren zu seiner herstellung.
DE3674582D1 (de) (s)-(-)-1-propyl-2',6'-pipecoloxylidid-hydrochloridmonohydrat, verfahren zu seiner herstellung und es enthaltendes pharmazeutisches praeparat.
DE58903737D1 (de) Flaechenlager und verfahren zu seiner herstellung.
DE68906928D1 (de) Leitfaehiges material und verfahren zu seiner herstellung.
DE68914598D1 (de) Keramischer Verbundwerkstoff und Verfahren zu seiner Herstellung.
ATA260590A (de) Glyzerinderivate, verfahren zu deren herstellung und sie enthaltende therapeutische zusammensetzungen
ATA22489A (de) Geschirrspülmittel und verfahren zu seiner herstellung

Legal Events

Date Code Title Description
ELJ Ceased due to non-payment of the annual fee